Shares of Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $1.02 and traded as high as $5.34. Mesoblast shares last traded at $5.30, with a volume of 600 shares.
Mesoblast Stock Performance
The company’s 50 day moving average is $1.49 and its 200 day moving average is $1.02.
About Mesoblast
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Further Reading
- Five stocks we like better than Mesoblast
- The How And Why of Investing in Oil Stocks
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Ride Out The Recession With These Dividend Kings
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What is a Secondary Public Offering? What Investors Need to Know
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
